Neoadjuvant and Adjuvant Nivolumab in HCC Patients Treated by Electroporation
Clinical trial NCT03630640 · TERMINATED
Trial details
- NCT number
- NCT03630640
- Sponsor
- Assistance Publique - Hôpitaux de Paris
- Status
- TERMINATED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2018-10-11
- Primary completion
- 2022-09-30
- Enrollment
- 43
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.